A Form 4 filed on September 3, 2026 disclosed that Muna Bhanji, a director of Veracyte, Inc. (NASDAQ:VCYT), sold 1,864 shares of common stock on September 1, 2026 pursuant to a pre-established Rule 10b5-1 trading plan.

Key Highlights

  • Reporting person: Muna Bhanji, identified as a Director of Veracyte, Inc.
  • Transaction: 1,864 shares of common stock disposed of (transaction code S) on September 1, 2026
  • Sale price: $42.97 per share
  • Remaining ownership: 42,718 shares of common stock held directly following the transaction
  • 10b5-1 plan: The sale was made pursuant to a Rule 10b5-1 plan adopted by Bhanji on June 2, 2026
  • Filing signed: Jonathan Wygant, acting as attorney-in-fact, signed on September 3, 2026

Veracyte Director Bhanji Reports Planned Share Sale Under Rule 10b5-1

According to the Form 4 filing, Muna Bhanji, a director of Veracyte, Inc., disposed of 1,864 shares of the company's common stock on September 1, 2026, at a price of $42.97 per share. The filing notes that no derivative securities were reported in connection with this transaction.

The filing discloses that the sale was carried out under a Rule 10b5-1 trading plan that Bhanji adopted on June 2, 2026. The form indicates the applicable checkbox was marked to reflect that the transaction was "made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c)." Following the reported sale, the filing states that Bhanji directly owns 42,718 shares of Veracyte common stock.

The Form 4 was filed with the United States Securities and Exchange Commission on September 3, 2026, and was signed by Jonathan Wygant as attorney-in-fact on behalf of the reporting person. No indirect beneficial ownership or derivative security positions were reported in the filing.

What Was Disclosed

The filing reported a single open-market sale of 1,864 shares of Veracyte, Inc. common stock by director Muna Bhanji at $42.97 per share on September 1, 2026, executed under a pre-established 10b5-1 plan, leaving a direct balance of 42,718 shares.